168 related articles for article (PubMed ID: 33791917)
21. Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.
Roch B; Coffy A; Jean-Baptiste S; Palaysi E; Daures JP; Pujol JL; Bommart S
Lung Cancer; 2020 May; 143():19-26. PubMed ID: 32200137
[TBL] [Abstract][Full Text] [Related]
22. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
23. First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age.
Petrillo A; Pappalardo A; Calabrese F; Tirino G; Pompella L; Ventriglia J; Laterza MM; Caterino M; Sforza V; Iranzo V; Biglietto M; Orditura M; Ciardiello F; Conzo G; Molino C; De Vita F
J Gastrointest Oncol; 2019 Oct; 10(5):910-917. PubMed ID: 31602329
[TBL] [Abstract][Full Text] [Related]
24. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
25. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
26. Association of sarcopenia with relative dose intensity of neoadjuvant chemotherapy in older patients with locally advanced esophageal cancer: A retrospective cohort study.
Harada T; Tsuji T; Ueno J; Hijikata N; Ishikawa A; Kotani D; Kojima T; Fujita T
J Geriatr Oncol; 2023 Sep; 14(7):101580. PubMed ID: 37478514
[TBL] [Abstract][Full Text] [Related]
27. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
Okubo S; Shinmura K; Kadota S; Nakayasu M; Kurosawa S; Nakayama H; Sakurai A; Ito C; Aisa Y; Nakazato T
Ann Hematol; 2024 Mar; 103(3):823-831. PubMed ID: 38010408
[TBL] [Abstract][Full Text] [Related]
29. [Sarcopenia in patients with pancreatic cancer, an independant prognostic factor].
Mandl J; Baumer S; Holtzem B; Theurer R; Zorger N; Pech O
Z Gastroenterol; 2023 Oct; 61(10):1365-1370. PubMed ID: 36482058
[TBL] [Abstract][Full Text] [Related]
30. Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer.
Shimura M; Mizuma M; Motoi F; Kusaka A; Aoki S; Iseki M; Inoue K; Douchi D; Nakayama S; Miura T; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Pancreatology; 2023 Jan; 23(1):65-72. PubMed ID: 36473785
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of modified FOLFIRINOX for unresectable advanced pancreatic cancer in elderly versus young patients: A multicenter retrospective cohort study.
Tezuka R; Iwashita T; Uemura S; Senju A; Yoshida K; Maruta A; Iwata K; Shimizu M
Pancreatology; 2022 Dec; 22(8):1134-1140. PubMed ID: 36404200
[TBL] [Abstract][Full Text] [Related]
32. Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients.
Takagi K; Inoue Y; Oba A; Ono Y; Sato T; Ito H; Saino Y; Saiura A; Takahashi Y
Biosci Trends; 2023 Sep; 17(4):310-317. PubMed ID: 37648468
[TBL] [Abstract][Full Text] [Related]
33. Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma.
Lellouche L; Barat M; Pellat A; Leroux J; Corre F; Hallit R; Assaf A; Brezault C; Dhooge M; Soyer P; Coriat R
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983212
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the cachexia index in patients with unresectable advanced gastric cancer receiving palliative chemotherapy: a retrospective single-center study.
Matsunaga T; Satio H; Sakano Y; Makinoya M; Shimizu S; Shishido Y; Miyatani K; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
Surg Today; 2024 Mar; 54(3):231-239. PubMed ID: 37526733
[TBL] [Abstract][Full Text] [Related]
35. Cachexia Versus Sarcopenia in Clinical Characteristics and Prognostic Value After Radical Gastrectomy for Gastric Cancer: A Large-Scale Prospective Study.
Zhuang CL; Dong QT; Shi HP; Zhang FM; Luo X; Wang WB; Yu Z; Chen XL; Wang SL
Ann Surg Oncol; 2022 Apr; 29(4):2348-2358. PubMed ID: 34797480
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of the G8 Geriatric Assessment Tool as a Prognostic Factor in Gemcitabine Plus Nab-paclitaxel Combination Therapy for Elderly Patients with Pancreatic Cancer.
Kadokura M; Mori Y; Takenaka Y; Yoda H; Yasumura T; Tanaka K; Amemiya F
JMA J; 2022 Oct; 5(4):512-519. PubMed ID: 36407075
[TBL] [Abstract][Full Text] [Related]
37. Association between Body Composition and Peripheral Neurotoxicity in Cancer Patients from North China Taking Nab-Paclitaxel.
Guo J; Zhao J; Gu M; Hou J; Xu T; Jiang Y; Jiang C; Li H; Li X; Liu G; Zhao L; Jin G; Shi Y; Liu T; Li Z; Zhang Z; Li Q
Nutr Cancer; 2023; 75(3):805-814. PubMed ID: 36533716
[TBL] [Abstract][Full Text] [Related]
38. Sarcopenia in pancreatic cancer: Effect on patient outcomes.
Choi MH; Yoon SB
World J Gastrointest Oncol; 2022 Dec; 14(12):2302-2312. PubMed ID: 36568942
[TBL] [Abstract][Full Text] [Related]
39. Cachexia and bladder cancer: clinical impact and management.
Lokeshwar SD; Press BH; Nie J; Klaassen Z; Kenney PA; Leapman MS
Curr Opin Support Palliat Care; 2021 Dec; 15(4):260-265. PubMed ID: 34698663
[TBL] [Abstract][Full Text] [Related]
40. Association of a newly developed Cancer Cachexia Score with survival in Stage I-III colorectal cancer.
Takano Y; Kodera K; Tsukihara S; Takahashi S; Yasunobu K; Kanno H; Ishiyama S; Saito R; Hanyu N; Eto K
Langenbecks Arch Surg; 2023 Apr; 408(1):145. PubMed ID: 37043018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
